|
06-09-2010, 10:27 PM
|
|||
|
|||
Human Genome Sciences says cancer drug fails study
Human Genome Sciences's potential cancer drug mapatumumab failed in a midstage study, the company said Wednesday. There was no difference in disease response or progression-free survival rates between patients receiving the drug for multiple myeloma and the control group, the company said.
    
|
 |
| Thread Tools | |
| Display Modes | |
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Seattle Genetics leukemia drug fails study | cancerfr | Leukemia | 0 | 09-14-2010 01:25 AM |
| Onyx Drug Fails Lung Cancer Study: BioBuzz | cancerfr | Lung Cancer | 0 | 06-14-2010 03:56 PM |
| Antisoma's lung cancer drug fails in phase-III study | cancerfr | Lung Cancer | 0 | 04-01-2010 04:05 AM |
| Human Genome Sciences Announces Results Of Randomized Phase 2 Trial Of Mapatumumab In | cancerfr | Lung Cancer | 0 | 03-19-2010 12:26 PM |
Linear Mode
